Skip to content
CompletedN/A

Ketamine Infusion Therapy for PTSD in Combat Veterans

NCT03088384 · Klarisana Physician Services PLLC

Closed to entry
Status
Not accepting participants
Not applicable
Phase
30
Target enrolment
1
Study sites
1 US states

What it is testing

Summary

Klarisana is conducting an observational study in San Antonio, Texas to see if there are tangible improvements in the symptoms of post traumatic stress disorder (PTSD) in combat veterans after receiving a series of six low-dose outpatient infusions of ketamine.

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

  • Participant score on the PTSD Checklist - 5 (PCL-5) after a series of six ketamine infusions.

    Measured over 3 weeks

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

18 Years to 75 Years
Ages
All
Sex
Accepted
Healthy volunteers
Inclusion Criteria: * The Veteran must be medically screened by Klarisana and be an appropriate candidate for ketamine therapy * The Veteran must be between the ages of 18 and 75. The study is open to men and women. * The Veteran must be able to speak and read the English language * The Veteran must have a diagnosis of post-traumatic stress disorder assigned by the Department of Veterans Affairs. Veterans of a foreign military are also eligible but they must have been diagnosed with PTSD by the equivalent veteran healthcare organization in their country of military service * The Veteran must have served in the US Military or a foreign military service in a designated combat zone. Documentation by a DD214 or equivalent is required * The PTSD that The Veteran is suffering from has to have been caused by service in combat * The PTSD that the Veteran is suffering from must be exerting a significant negative effect on his/her life Exclusion Criteria: * The Veteran must NOT be taking lamotrigine (Lamictal) or any monoamine oxidase inhibitor antidepressants * The Veteran must not be currently enrolled in any other studies offering therapy for PTSD * Veteran may NOT have uncontrolled blood pressure or congestive heart failure * Veteran may NOT have a diagnosis of psychosis or any diagnosis on the psychosis spectrum

Where

1 study site

FacilityCityRegionCountry
KlarisanaSan AntonioTexasUnited States

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT03088384 on ClinicalTrials.gov →

Last updated in the registry 2018-10-02. Registry records change; this page reflects the data build of 2026-08-25.

Related

Where this trial sits